Blocking this pathway with dehydroxymethylepoxyquinomicin (DHMEQ) resulted in decreased proliferation of fibroblasts and less deposition of type I collagen, implying that NF-κB pathway is involved in keloid pathogenesis (40). The gene discussed is NFKB1; the disease is keloid.